Market Insight: by Dr. Oded Ben-Joseph and Dr. Echoe Bouta
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Recent advances in cell-based therapy technology and FDA approvals have demonstrated the feasibility of of treating difficult diseases. Given the progress, we examined recent market dynamics in a 3.5-year period starting in January 2015 by analyzing clinical trials, financing events, M&As and IPOs to assess the overall activity of the sector and interest by venture capitalists and strategic players
Tuesday, July 23 6:00-7:30pm Cost: This event is hosted by Dr. Oded Ben-Joseph (Darwin 1988), Managing Director, Outcome Capital, LLC, and is free to attend with prior RSVP. Outcome Capital, LLC 99 High Street, Suite 2900 Boston, MA RSVP to Megan Cokely at email@example.com Cambridge in America’s Boston Regional Committee invites you to another exclusive event for […]Read More
Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science June 4, 2019, Boston, MA Outcome Capital, LLC announced today that it has expanded the Outcome Capital Internship Program to include Partners HealthCare Innovation. The program will provide research fellows at Massachusetts General Hospital, Brigham […]Read More